Download PDF
Aktuelle Neurologie 2003; 30(7): 344-349
DOI: 10.1055/s-2003-41891
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Vagusnervstimulation: Derzeitiger Stellenwert in der Epilepsietherapie

Vagus Nerve Stimulation: Current Status in Epilepsy TherapyG.  Krämer1 , A.  Hufnagel2
  • 1Schweizerisches Epilepsie-Zentrum, Zürich
  • 2Neurologische Universitätsklinik, Essen
Further Information

Publication History

Publication Date:
04 September 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Vagusnervstimulation (VNS) ist eine palliative Behandlungsmethode pharmakoresistenter Epilepsien, mit der bei ca. 30 - 40 % der Patienten eine Reduktion der Anfallsfrequenz um mehr als 50 % erreicht werden kann. Die häufigsten Nebenwirkungen dieser im Allgemeinen gut tolerierten Methode sind Heiserkeit, laryngeale Missempfindungen, Husten oder Dyspnoe während der Stimulation. Ihr Einsatz sollte ernsthaft erwogen werden, wenn eine nachgewiesene Pharmakoresistenz besteht und ein resektiver epilepsiechirurgischer Eingriff nicht oder nur mit relativ hohem Risiko möglich ist. Nach der Implantation ist eine medikamentöse Behandlung weiterhin zwingend notwendig. Sie kann zum Teil jedoch vereinfacht werden und somit besser verträglich sein. Die Nachsorge ist teilweise aufwändig, weshalb die VNS an spezialisierten Zentren durchgeführt werden sollte.

Abstract

Vagus nerve stimulation (VNS) is a palliative method for treatment of medically refractory epilepsies and can result in a reduction of seizure frequency of more than 50 % in approximately 30 - 40 % of the patients. Most commonly reported side effects of this usually well tolerated method are hoarseness, laryngeal dysaesthesia, cough or dyspnea. Implantation of a vagus nerve stimulator should be considered in pharmacoresistant epilepsies in which resective epilepsy surgery is not possible or would bear a high risk. After implantation, further medical therapy is still mandatory. However, it may be possible to reduce co-medications thus improving tolerability. Follow-up is essential and in some patients time-consuming. VNS should be performed at specialised epilepsy centers.

Literatur

  • 1 Bailey P, Bremer F. A sensory cortical representation of the vagus nerve with a note on the effects of low pressure on the cortical electrogram.  J Neurophysiol. 1938;  1 405-412
    CrossrefPubMedGoogle Scholar
  • 2 Zabara J. Peripheral control of hypersynchronous discharge in epilepsy.  Electroencephalogr Clin Neurophysiol. 1985;  61 (abstract) 162
    PubMedGoogle Scholar
  • 3 Schachter S C, Schmidt D. Vagus Nerve Stimulation. Second edition. London, New York; Martin Dunitz 2003
    Google Scholar
  • 4 Agostini E, Chonnock J E, Daly M D, Murray J G. Functional and histological studies of the vagus nerve and its branches to the heart, lungs, and abdominal viscera in the cat.  J Physiol. 1957;  135 182-205
    PubMedGoogle Scholar
  • 5 Saper C B, Kibbe M R, Hurley K M. et al . Brain natriuretic peptide-like immunoreactive innervation of the cardiovascular and cerebrovascular systems in the rat.  Circ Res. 1990;  67 1345-1354
    PubMedGoogle Scholar
  • 6 Woodbury D M, Woodbury J W. Effects of vagal stimulation on experimentally induced seizures in rats.  Epilepsia. 1990;  31 (Suppl 2) S7-S19
    PubMedGoogle Scholar
  • 7 Henry T R. Therapeutic mechanisms of vagus nerve stimulation.  Neurology. 2002;  59 (Suppl 4) 3-14
    PubMedGoogle Scholar
  • 8 Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation.  Epilepsia. 1992;  33 1005-1012
    CrossrefPubMedGoogle Scholar
  • 9 McLachlan R S. Suppression of interictal spikes and seizures by stimulation of the vagus nerve.  Epilepsia. 1993;  34 918-923
    PubMedGoogle Scholar
  • 10 Takaya M, Terry W J, Naritoku D K. Vagus nerve stimulation induces a sustained anticonvulsant effect.  Epilepsia. 1996;  37 1111-1116
    PubMedGoogle Scholar
  • 11 Krahl S E, Clark K B, Smith D C, Browning R A. Locus coeruleus lesions suppress the seizure-attentuating effects of vagus nerve stimulation.  Epilepsia. 1998;  39 709-714
    CrossrefPubMedGoogle Scholar
  • 12 Hammond E J, Uthmann B M, Reid S A, Wilder B J. Electrophysiological studies of cervical vagus nerve stimulation in humans.  Epilepsia. 1992;  23 1013-1020
    PubMedGoogle Scholar
  • 13 Salinksy M C, Burchiel K J. Vagus nerve stimulation has no effect on awake EEG rhythms in humans.  Epilepsia. 1993;  34 299-304
    PubMedGoogle Scholar
  • 14 Olejniczak P W, Fish B J, Carey M. et al . The effect of vagus nerve stimulation on epileptiform activity recorded from hippocampal depth electrodes.  Epilepsia. 2001;  42 423-429
    CrossrefPubMedGoogle Scholar
  • 15 Henry T R, Bakay R A, Votaw J R. et al . Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy I: Acute effects at high and low levels of stimulation.  Epilepsia. 1998;  39 983-990
    PubMedGoogle Scholar
  • 16 Ring H A, White S, Costa D C. et al . A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy.  Seizure. 2000;  9 380-384
    CrossrefPubMedGoogle Scholar
  • 17 Laere K van, Vonck K, Boon P. et al . Vagus nerve stimulation in refractory epilepsy: SPECT activation study.  J Nucl Med. 2000;  41 1145-1154
    PubMedGoogle Scholar
  • 18 Ben-Menachem E, Manon-Espaillat R, Ristanovic R. et al . Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures.  Epilepsia. 1994;  35 616-626
    PubMedGoogle Scholar
  • 19 Handforth A, Giorgio C M de, Schachter S C. et al . Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial.  Neurology. 1998;  51 48-55
    CrossrefPubMedGoogle Scholar
  • 20 Morris G L, Mueller W M. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01 - E05.  Neurology. 2000;  51 48-55
    PubMedGoogle Scholar
  • 21 Scherrmann J, Hoppe C, Kral T. et al . Vagus nerve stimulation: clinical experience in a large patient series.  J Clin Neurophysiol. 2001;  18 408-414
    PubMedGoogle Scholar
  • 22 Schachter S C. Vagus nerve stimulation therapy: summary.  Neurology. 2002;  59 (Suppl 4) 15-20
    PubMedGoogle Scholar
  • 23 Helmers S L, Wheless J W, Frost M. et al . Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study.  J Child Neurol. 2001;  16 843-848
    CrossrefPubMedGoogle Scholar
  • 24 Sperner J, Altmann B, Borussiak P. et al .Vagusnerv-Stimulation bei Kindern zur Therapie pharmakoresistenter Epilepsien. In: Korintheberg R (Hrsg) Aktuelle Neuropädiatrie 2002. Nürnberg; Novartis Pharma Verlag 2003: 520-524
    Google Scholar
  • 25 Tatum O W, Moore D B, Stecker M M. et al . Ventricular asystole during vagus nerve stimulation for epilepsy in humans.  Neurology. 1999;  52 1267-1269
    CrossrefPubMedGoogle Scholar
  • 26 Andriola M R, Rosenweig T, Vlay S. Vagus nerve stimulator (VNS): induction of asystole during implentation with subsequent successful stimulation (abstract).  Epilepsia. 2000;  41 (Suppl 7) 223
    PubMedGoogle Scholar
  • 27 Zumsteg D, Jenny D, Wieser H G. Vocal cord adduction during vagus nerve stimulation for treatment of epilepsy.  Neurology. 2000;  54 1388-1389
    PubMedGoogle Scholar
  • 28 Malow B A, Edwards J, Marzec M. et al . Effects of vagus nerve stimulation on respiration during sleep: a pilot study.  Neurology. 2000;  55 1450-1454
    CrossrefPubMedGoogle Scholar
  • 29 Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety.  J Clin Neurophysiol. 2001;  18 415-418
    CrossrefPubMedGoogle Scholar
  • 30 Dodrill C B, Morris G L. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy.  Epilepsy Behav. 2001;  2 46-53
    CrossrefPubMedGoogle Scholar
  • 31 Hoppe C, Helmstaedter C, Scherrmann J, Elger C E. No evidence for cognitive side effects after 6 months of vagus nerve stimulation in epilepsy patients.  Epilepsy Behav. 2001;  2 351-356
    CrossrefPubMedGoogle Scholar
  • 32 Sackeim H A, Keilp J G, Rush A J. et al . The effects of vagus nerve stimulation on cognitive performance in patients with treatment resistant depression.  Neuropsychiatry Neuropsychol Behav Neurol. 2001;  14 53-62
    PubMedGoogle Scholar
  • 33 Kwan P, Brodie M J. Early identification of refractory epilepsy.  N Engl J Med. 2000;  342 314-319
    CrossrefPubMedGoogle Scholar
  • 34 Privitera M D, Welty T E, Ficker D M, Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev 2001 1 CD002896
    Google Scholar
  • 35 Elger G, Hoppe C, Falkai P. et al . Vagus nerve stimulation is associated with mood improvements in epilepsy patients.  Epilepsy Res. 2000;  42 203-210
    PubMedGoogle Scholar
  • 36 Ben-Menachem E. Personal communication. 
    Google Scholar
  • 37 Boon P, Vonck K, D'Have M. et al . Cost-benefit of vagus nerve stimulation for refractory epilepsy.  Acta Neurol Belg. 1999;  99 275-280
    PubMedGoogle Scholar
  • 38 Forbes R B, MacDonald S, Eljamel S, Roberts R C. Cost-utility analysis of vagus nerve stimulators for adults with medically refractory epilepsy.  Seizure. 2003;  12 249-256
    CrossrefPubMedGoogle Scholar

Dr. med. Günter Krämer

Schweizerisches Epilepsie-Zentrum

Bleulerstraße 60

8008 Zürich · Schweiz

Email: g.kraemer@swissepi.ch

      >